The New Boundaries of Corporate Affairs @ T2B's Virtual Forum


Hi!

Corporate affairs keeps getting broader, but there’s no single model for what belongs inside the function... or how much the function should directly own.

On Day 2 of our upcoming Virtual Biopharma Comms Forum, we’re bringing together leaders working within very different company structures to compare how those boundaries are taking shape in practice.

The New Boundaries of Corporate Affairs

Panel discussion @ Virtual Biopharma Comms Forum | Wednesday, October 7th @ 2:10 p.m. ET

Joining us:

  • Megan Humphreys, VP, Corporate Communications, Evommune
  • Eric McKeeby, Head of Corporate Communications, insitro
  • Bernadette Murdoch, Head of Employee Communications and CEA Business Partner for R&D & Business Development, CSL
  • Yvonne Sprow, SVP, Global Communications, Novavax
  • Moderator: Josh Deutchman, Gen AI Enablement and Communications, Wells Fargo

Together, they’ll get into some of the practical choices behind how corporate affairs operates today:

  • How the role changes when areas like IR, policy, reputation, and employee engagement formally sit within corporate affairs, vs. when comms is brought in to advise, connect, or influence without owning them
  • What to build inside the function as company needs, resources, and expectations change
  • How an expanding remit affects team structure, priorities, and decision rights

It’s a conversation at the heart of this year’s Forum theme, Owning the Outcome: getting clearer about responsibility and accountability even when the org chart doesn’t provide an easy answer.

Register for one or both days of T2B's Virtual Forum

DAY 1: Tuesday, October 6th | 10:30 a.m.-1:45 p.m. ET
​
REGISTER FOR DAY 1​

DAY 2: Wednesday, October 7th | 2-4 p.m. ET
​
REGISTER FOR DAY 2​

T2B Pro and Student members can attend free as part of their membership. T2B Basic members can register for $275 per day.

More of the lineup coming next week!

Lynnea

T2B Monthly

Read more from T2B Monthly

Hi! A quick reminder that our September Comm Convo is tomorrow, September 24th, at 12 p.m. ET / 9 a.m. PT / 5 p.m. BST. We called this session "Beyond the Binder in the Era of Constant Crisis" because so much of crisis readiness now comes down to judgment: knowing what deserves preparation, what requires an immediate response, and how to make good decisions when the facts are incomplete or still changing. What we'll get into tomorrow: Prioritizing what to prepare for based on the stage and...

Hi! When Jessica Freifeld signed on to support thought leadership and LinkedIn for Parabilis' CEO, she had no idea that she’d eventually be leading the communications effort for the largest IPO for a venture-backed biotech company. But she soon found herself working alongside not only the CEO, but also the finance team, banks, legal counsel, and agency partners to sharpen a differentiated investor narrative for the company. On Day 2 of our upcoming Virtual Biopharma Comms Forum, Jessica will...

Hi! For us at T2B and probably for most of you, too, September is not only the return from summertime, but also the turn around the corner that takes us through the end of the year and into JPM. This year feels especially jam-packed, so before anything else, I want to thank everyone who joined us at our T2Bmeets last week along the Eastern Seaboard, in D.C., Philly, and Boston for making the time — time away from work, client deadlines, family, travel, and everything else competing for it. A...